外用冻干人纤维蛋白粘合剂(Fibrin Sealant (Human)(Baxter)) - 在研适应症：烧伤_专利_临床

概要

基本信息

药物类型

非重组凝血因子

别名

Artiss

靶点-

作用机制-

治疗领域

其他疾病

在研适应症

烧伤

非在研适应症-

原研机构

Baxter Healthcare Corp.

在研机构

Baxter Healthcare Corp.

非在研机构-

最高研发阶段批准上市

首次获批日期

美国 (2008-03-19),

烧伤

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

序列信息

Sequence Code 15023190L

Sequence Code 452991633γ

Sequence Code 157626H

Sequence Code 802074131β

Sequence Code 4698119α

关联

8

项与外用冻干人纤维蛋白粘合剂相关的临床试验

NCT04931615 / Completed临床4期IIT

The Influence of ARTISS on Post-operative Abdominal Drainage and Seroma Formation in DIEP/MS-TRAM Free Flap Breast Reconstruction Patients

The Influence of ARTISS on post-operative abdominal drainage and seroma formation in DIEP/MS-TRAM free flap breast reconstruction patients.

开始日期2022-02-01

申办/合作机构

Mid and South Essex NHS Foundation Trust

EUCTR2014-000727-25-NL / Unknown status临床4期

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial.

开始日期2017-03-28

申办/合作机构-

NL-OMON41295 / RecruitingN/A

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial. - The use of ARTISS to prevent seroma: a randomized controlled trial

开始日期2015-07-01

申办/合作机构-

100 项与外用冻干人纤维蛋白粘合剂相关的临床结果

登录后查看更多信息

100 项与外用冻干人纤维蛋白粘合剂相关的转化医学

登录后查看更多信息

100 项与外用冻干人纤维蛋白粘合剂相关的专利（医药）

登录后查看更多信息

16

项与外用冻干人纤维蛋白粘合剂相关的文献（医药）

2024-09-01·Burns

Artiss fibrin sealant for the fixation of autografts in pediatric burn care

Article

作者: Cappiello, Clint ; Chidiac, Charbel ; Reuland, Carolyn ; Hodgman, Erica

BACKGROUNDTraditional fixation of autografts in the treatment of burns involves the use of sutures and staples. A novel fibrin sealant, Artiss, has been introduced as an alternate method of fixation and has shown promising safety and efficacy results in the adult population. Our study assessed the effectiveness of fibrin sealant to secure autologous split thickness skin grafts (ASTSG) in the pediatric burn population.METHODSWe performed a retrospective cohort study of pediatric patients under 18 years of age who received autografting for the treatment of burns at our institution between 2017 and 2023. We compared ASTSG secured with fibrin sealant to those managed traditionally with sutures or staples. Outcomes of interest include the need for return trips to the operating room (OR), time to wound healing, graft take, and total time in the operating room.RESULTS83 patients underwent a total of 142 individual ASTSGs for management of unique body area injuries. 66.3 % were male, median age was 79 months, and scald was the most common mechanism of injury (41.0 %). Forty-five (39.5 %) traditionally affixed ASTSG required at least one return to the OR while only one (3.6 %) ASTSG secured with fibrin sealant required an additional return to the OR (p < 0.001). Graft take was similar in both groups (92.9 % for fibrin sealant vs. 93.9 % for traditional methods, p = 1). Time to wound healing was also similar: 16 vs. 15 days for fibrin glue and traditional methods, respectively (p = 0.23).CONCLUSIONOutcomes from autograft fixation with fibrin sealant were comparable to those treated with traditional methods, with a reduction in the need for return trips to the operating room. These data suggest that fibrin sealant is a suitable alternative to traditional fixation methods in pediatric autografting.

2024-05-01·Head & Neck

Drainless, day‐case lateral neck dissection with Artiss™ fibrin sealant: A prospective cohort study

Article

作者: Tabaksert, Ayla ; Lester, Shane ; Walters, Holt ; James, Tobias ; Rusius, Christopher

AbstractObjectiveLateral neck dissection (LND) is performed for staging/treatment of head and neck lesions. This traditionally includes placement of a drain and inpatient admission. Drainless, day‐case head and neck surgery is attractive due to cost‐effectiveness and reduced length of stay, but evidence is lacking in LND. We aim to investigate Artiss™ as an alternative to drain placement, facilitating day‐case LND.MethodsA prospective review was conducted of patients who underwent LND in a UK hospital over a 22‐month period.ResultsThirty‐nine patients were identified (27 Artiss™ only; 12 Artiss™ with a drain). Eight Artiss™ only patients were day‐case. All drains were removed by post‐operative day 2. There was no statistically significant difference in the number of complications between the two groups.ConclusionThis observational study demonstrates that for selected patients, Artiss™ could facilitate drainless, day‐case LND. Further controlled studies with matched groups and larger numbers are required to validate this.

2021-08-01·Plastic Surgery4区 · 医学

Fibrin Sealant Artiss Compared to Progressive Tension Sutures With Stratafix in the Management of Wound Drainage Following Post-Bariatric Body-Contouring Surgery

4区 · 医学

Article

作者: Schwarzenberger, Sarah ; Langer, Stefan ; Spindler, Nick ; Zeplin, Philip H.

Background: Post-bariatric body-contouring surgery is one of the most rapidly growing areas in plastic surgery. One of the most common complications following post-bariatric body-contouring surgery is seroma. There are a number of approaches to reducing wound drainage and seroma formation. A promising strategy to reduce these complications is to develop effective methods for reducing dead space between the tissue layers. Methods: We conducted a retrospective trial assessing the use of human fibrin sealant Artiss in comparison to progressive tension sutures (PTS) with Stratafix, a bidirectional barbed suture device in patients undergoing post-bariatric body-contouring surgery. Thirty-six patients for abdominoplasty or lower-body-lift were evaluated. Treatment patients underwent procedure with fibrin sealant applied to adapt the tissue layers. Control patients underwent an identical procedure but with PTS. Primary outcome measures included total wound drainage and time to drain removal. Results: The use of Artiss in abdominoplasty was associated with a mean drain volume that was significantly higher and more days that were needed to remove all drains compared to the PTS group. In body-lift, the mean drain volume and number of days needed to remove all drains tended to be higher when using Artiss compared to the PTS group. Conclusion: The use of Artiss in post-bariatric body-contouring surgery did not decrease the rate of seromas and the length of time required for post-surgical drains when compared to PTS.

100 项与外用冻干人纤维蛋白粘合剂相关的药物交易

登录后查看更多信息